JAFFER A. AJANI, M.D.; C. HUMBERTO CARRASCO, M.D.; CHUSILP CHARNSANGAVEJ, M.D.; NAGUIB A. SAMAAN, M.D.; BERNARD LEVIN, M.D.; SIDNEY WALLACE, M.D.
The value of sequential percutaneous hepatic artery embolization with polyvinyl alcohol particles was examined in 22 patients with islet cell carcinoma metastatic to the liver. Nine patients had gastrinoma, 2 had glucagonoma, and 11 had no discernible hormonal secretions or syndromes. Ninety-seven embolizations were done with a median number of 4 (range, 1 to 12) per patient. The interval between embolizations ranged from 1 to 8 months. Twelve of twenty evaluable patients had a partial remission, frequently associated with subjective improvement and decrease in hormone levels. The projected median survival of all 22 patients from the initiation of embolization is 33.7 months (range, 1 to 72). Nausea, vomiting, fever, and abdominal pain occurred with each embolization and subsided usually by day 10 (range, 3 to 35). Sequential hepatic artery occlusion is an effective method for prolonged palliation in this selected group of patients.
AJANI JA, CARRASCO CH, CHARNSANGAVEJ C, SAMAAN NA, LEVIN B, WALLACE S. Islet Cell Tumors Metastatic to the Liver: Effective Palliation by Sequential Hepatic Artery Embolization. Ann Intern Med. ;108:340–344. doi: 10.7326/0003-4819-108-3-340
Download citation file:
Published: Ann Intern Med. 1988;108(3):340-344.
End-of-Life Care, Gastroenterology/Hepatology, Gastrointestinal Cancer, Hematology/Oncology, Liver Disease.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use